导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -8.85% | 812/1050 |
| 近一周 | -2.57% | 836/1104 |
| 近一月 | -2.94% | 526/1103 |
| 近一季 | -2.84% | 389/1092 |
| 近半年 | -5.89% | 651/1070 |
| 近一年 | -7.33% | 714/1018 |
| 近两年 | 67.70% | 390/926 |
| 近三年 | 37.14% | 349/834 |
| 成立以来 | 42.03% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-9.66% 991/1070 |
-1.64% 730/1101 |
- - |
- - |
| 2025 | 59.89% 107/1065 |
20.14% 24/1014 |
1.35% 562/1038 |
41.53% 165/1050 |
-7.22% 810/1065 |
| 2024 | -0.98% 610/1011 |
-7.64% 678/960 |
7.97% 34/983 |
3.14% 919/991 |
-3.73% 586/1011 |
| 2023 | -6.36% 234/952 |
3.78% 388/880 |
-2.02% 300/895 |
-6.04% 370/915 |
-1.99% 231/952 |
| 2022 | -29.83% 625/867 |
-28.64% 733/773 |
17.83% 55/806 |
-21.61% 774/845 |
6.47% 149/867 |
| 2021 | -11.26% 492/740 |
-9.64% 483/580 |
13.68% 267/659 |
-10.95% 532/704 |
-2.98% 541/740 |
| 2020 | 48.92% 241/554 |
-7.06% 340/419 |
20.71% 273/466 |
5.72% 349/517 |
25.57% 61/554 |
| 2019 | - - |
- - |
1.48% 204/1228 |
1.45% 293/390 |
4.31% 356/410 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 前海开源沪港深非周期股票A VS. 东吴新产业精选股票A(580008) |